Recent years have witnessed remarkable advances in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as hopeful https://majahjwm252386.blog-mall.com/39661652/exploring-the-future-of-type-2-diabetes-treatment-retatrutide-and-trizepatide